Use of the linear-quadratic radiobiological model for quantifying kidney response in targeted radiotherapy.
暂无分享,去创建一个
[1] S. Dische,et al. The rationale for continuous, hyperfractionated, accelerated radiotherapy (CHART). , 1990, International journal of radiation oncology, biology, physics.
[2] J. Fowler,et al. A new incomplete-repair model based on a 'reciprocal-time' pattern of sublethal damage repair. , 1999, Acta oncologica.
[3] S. Goddu,et al. Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] G. Barendsen,et al. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. , 1982, International journal of radiation oncology, biology, physics.
[5] Applied Radiobiology and Bioeffect Planning , 2001 .
[6] M. Konijnenberg,et al. Is the renal dosimetry for [90Y-DOTA0,Tyr3]octreotide accurate enough to predict thresholds for individual patients? , 2003, Cancer biotherapy & radiopharmaceuticals.
[7] P. Lambin,et al. Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate? , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] M. Williams,et al. Basic clinical radiobiology , 1994, British Journal of Cancer.
[9] D A Morgan,et al. The role of biologically effective dose (BED) in clinical oncology. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).
[10] P. Canney,et al. Derivation and application of equations describing the effects of fractionated protracted irradiation, based on multiple and incomplete repair processes. Part 2. Analysis of mouse lung data. , 1993, International journal of radiation biology.
[11] J. Hendry,et al. Two components of repair in irradiated kidney colony forming cells. , 1994, International journal of radiation biology.
[12] R. Dale,et al. A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd , 2001, Physics in medicine and biology.
[13] J. Fowler. The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.
[14] Ethaar El-Emir,et al. The Nonuniformity of Antibody Distribution in the Kidney and its Influence on Dosimetry , 2003, Radiation research.
[15] S. Goddu,et al. Proliferation and the advantage of longer-lived radionuclides in radioimmunotherapy. , 1998, Medical physics.
[16] R G Dale,et al. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. , 1985, The British journal of radiology.
[17] George Sgouros,et al. MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] R G Dale,et al. Dose-rate effects in targeted radiotherapy. , 1996, Physics in medicine and biology.
[19] H D Thames,et al. An 'incomplete-repair' model for survival after fractionated and continuous irradiations. , 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[20] C. Armpilia,et al. The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants. , 2003, International journal of radiation oncology, biology, physics.